QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) 期刊论文 MOLECULAR CANCER, 2021, 卷号: 20, 期号: 1, 页码: 1 作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang 收藏  |  浏览/下载：57/0  |  提交时间：2021/11/04 Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文 Molecular Cancer, 2021, 卷号: 20, 期号: 1 作者:  Zhang,Tao;  Qu,Rong;  Chan,Shingpan;  Lai,Mengzhen;  Tong,Linjiang 收藏  |  浏览/下载：41/0  |  提交时间：2021/11/04 PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma 期刊论文 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6, 期号: 1, 页码: 3 作者:  Xie, Qin;  Chi, Shuaishuai;  Fang, Yanfen;  Sun, Yiming;  Meng, Linghua 收藏  |  浏览/下载：18/0  |  提交时间：2021/05/24 Integrative Proteomic Characterization of Human Lung Adenocarcinoma 期刊论文 CELL, 2020, 卷号: 182, 期号: 1, 页码: 245-+ 作者:  Xu, Jun-Yu;  Zhang, Chunchao;  Wang, Xiang;  Zhai, Linhui;  Ma, Yiming 收藏  |  浏览/下载：51/0  |  提交时间：2020/12/24 Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文 MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15 作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang 收藏  |  浏览/下载：39/0  |  提交时间：2020/07/01 Non-small cell lung cancer (NSCLC)  EGFR T790M  Small-molecule inhibitor  Drug resistance  Ack1   Discovery of JND3229 as a New EGFR(C797S) Mutant Inhibitor with In Vivo Monodrug Efficacy 期刊论文 ACS MEDICINAL CHEMISTRY LETTERS, 2018, 卷号: 9, 期号: 11, 页码: 1123-1127 作者:  Lu, Xiaoyun;  Zhang, Tao;  Zhu, Su-Jie;  Xun, Qiuju;  Tong, Lingjiang 收藏  |  浏览/下载：107/0  |  提交时间：2019/01/08 EGFR(C797s)  Clinical resistance  Fourth-generation nhibitors  Monodrug efficacy   Identification of recurrent USP48 and BRAF mutations in Cushing's disease 期刊论文 NATURE COMMUNICATIONS, 2018, 卷号: 9 作者:  Chen, Jianhua;  Jian, Xuemin;  Deng, Siyu;  Ma, Zengyi;  Shou, Xuefei 收藏  |  浏览/下载：117/0  |  提交时间：2019/01/08 EZH2 inhibitors abrogate upregulation of H3K27me3 by CDK9 inhibitors and potentiate its antitumor activity in DLBCL 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 13, 页码: 2 作者:  Xie, Shao;  Wei, Fan;  Sun, Yiming;  Gao, Yinglei;  Ding, Jian 收藏  |  浏览/下载：2/0  |  提交时间：2020/07/01 dw10075anovelselectiveandsmallmoleculeinhibitorofvegfrexhibitsantitumoractivitiesbothinvitroandinvivo 期刊论文 actapharmacologicasinica, 2016, 卷号: 37, 期号: 3, 页码: 398 作者:  Ll Mengyuan;  Lv Yongcong;  Tong Linjiang;  Peng Ting;  Qu Rong 收藏  |  浏览/下载：6/0  |  提交时间：2020/07/01 DW10075  VEGF/VEGF receptor inhibitor  Antitumor  Angiogenesis  U87-MG human glioblastoma   Novel microtubule-targeted agent 6-chloro-4-(methoxyphenyl) coumarin induces G_2-M arrest and apoptosis in HeLa cells 期刊论文 Acta Pharmacologica Sinica, 2012, 卷号: 33, 期号: 3, 页码: 407 作者:  Ma Yiming;  Zhou Yubo;  Xie Chuanming;  Chen Dongmei;  Li Jia 收藏  |  浏览/下载：3/0  |  提交时间：2020/07/01 ACTIVATED PROTEIN-KINASE  TUBULIN-BINDING AGENT  IN-VIVO  ANTIMICROBIAL ACTIVITY  ANTICANCER ACTIVITY  CYCLE ARREST  CANCER-CELLS  DERIVATIVES  INHIBITOR  RESISTANT  anticancer drug  6-chloro-4-(methoxyphenyl) coumarin  cell cycle arrest  microtubule depolymerization  apoptosis